Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1990 Oct;64(10):5209–5213. doi: 10.1128/jvi.64.10.5209-5213.1990

Expression of herpes simplex virus type 1 glycoproteins in interferon-treated human neuroblastoma cells.

S Chatterjee 1, P Burns 1
PMCID: PMC248020  PMID: 2168998

Abstract

Human alpha interferon (IFN) significantly inhibits the replication of herpes simplex virus type 1 in human neuroblastoma cells. This inhibitory effect can be blocked by pretreatment with antiserum to IFN. We observed no significant differences in the expression of major nucleocapsid proteins, including VP5, between IFN-treated and untreated neuroblastoma cells. Electron micrographs demonstrated that there were distinct viral nucleocapsids within IFN-treated neuroblastoma cells. The expression of glycoproteins B and E was significantly reduced in these IFN-treated cells. On the other hand, glycoprotein D, although reduced in quantity, was expressed after IFN treatment. An immunofluorescence assay of the IFN-treated and virus-infected cells detected glycoprotein D in the Golgi complexes and in the nuclear membranes. Our results indicate that human alpha IFN may be useful in the study of gene expression in IFN-treated cells of neuronal origin.

Full text

PDF
5209

Images in this article

5210Image
on p.5210
5211Image
on p.5211
5212Image
on p.5212
5212Image
on p.5212
5212Image
on p.5212

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baringer J. R., Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973 Mar 29;288(13):648–650. doi: 10.1056/NEJM197303292881303. [DOI] [PubMed] [Google Scholar]
  2. Bastian F. O., Rabson A. S., Yee C. L., Tralka T. S. Herpesvirus hominis: isolation from human trigeminal ganglion. Science. 1972 Oct 20;178(4058):306–307. doi: 10.1126/science.178.4058.306. [DOI] [PubMed] [Google Scholar]
  3. Baucke R. B., Spear P. G. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J Virol. 1979 Dec;32(3):779–789. doi: 10.1128/jvi.32.3.779-789.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chatterjee S., Bradac J. A., Hunter E. Effect of monensin on Mason-Pfizer monkey virus glycoprotein synthesis. J Virol. 1982 Dec;44(3):1003–1012. doi: 10.1128/jvi.44.3.1003-1012.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chatterjee S., Cheung H. C., Hunter E. Interferon inhibits Sendai virus-induced cell fusion: an effect on cell membrane fluidity. Proc Natl Acad Sci U S A. 1982 Feb;79(3):835–839. doi: 10.1073/pnas.79.3.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chatterjee S., Hunter E. Recombinant human interferons inhibit replication of Mason-Pfizer monkey virus in primate cells. Virology. 1987 Apr;157(2):548–551. doi: 10.1016/0042-6822(87)90299-6. [DOI] [PubMed] [Google Scholar]
  7. Chatterjee S., Hunter E. The characterization of Mason-Pfizer monkey virus-induced cell fusion. Virology. 1979 Jun;95(2):421–433. doi: 10.1016/0042-6822(79)90497-5. [DOI] [PubMed] [Google Scholar]
  8. Chatterjee S., Hunter E., Whitley R. Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus. J Virol. 1985 Nov;56(2):419–425. doi: 10.1128/jvi.56.2.419-425.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chatterjee S., Koga J., Whitley R. J. A role for herpes simplex virus type 1 glycoprotein E in induction of cell fusion. J Gen Virol. 1989 Aug;70(Pt 8):2157–2162. doi: 10.1099/0022-1317-70-8-2157. [DOI] [PubMed] [Google Scholar]
  10. Chatterjee S., Lakeman A. D., Whitley R. J., Hunter E. Effect of cloned human interferons on the replication of and cell fusion induced by herpes simplex virus. Virus Res. 1984 Jan;1(1):81–87. doi: 10.1016/0168-1702(84)90037-6. [DOI] [PubMed] [Google Scholar]
  11. Chatterjee S., Whitley R. J. Effect of recombinant hybrid human interferon on replication and morphogenesis of HSV-1 in monkey cells. Virus Res. 1989 Jan;12(1):33–41. doi: 10.1016/0168-1702(89)90051-8. [DOI] [PubMed] [Google Scholar]
  12. Douglas J. M., Critchlow C., Benedetti J., Mertz G. J., Connor J. D., Hintz M. A., Fahnlander A., Remington M., Winter C., Corey L. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med. 1984 Jun 14;310(24):1551–1556. doi: 10.1056/NEJM198406143102402. [DOI] [PubMed] [Google Scholar]
  13. Eberle R., Courtney R. J. gA and gB glycoproteins of herpes simplex virus type 1: two forms of a single polypeptide. J Virol. 1980 Dec;36(3):665–675. doi: 10.1128/jvi.36.3.665-675.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fuller A. O., Santos R. E., Spear P. G. Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. J Virol. 1989 Aug;63(8):3435–3443. doi: 10.1128/jvi.63.8.3435-3443.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gloger I., Panet A. Synthesis of herpes simplex virus proteins in interferon-treated human cells. J Gen Virol. 1984 Jun;65(Pt 6):1107–1111. doi: 10.1099/0022-1317-65-6-1107. [DOI] [PubMed] [Google Scholar]
  16. Gompels U., Minson A. The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology. 1986 Sep;153(2):230–247. doi: 10.1016/0042-6822(86)90026-7. [DOI] [PubMed] [Google Scholar]
  17. Koga J., Chatterjee S., Whitley R. J. Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies. Virology. 1986 Jun;151(2):385–389. doi: 10.1016/0042-6822(86)90059-0. [DOI] [PubMed] [Google Scholar]
  18. Longnecker R., Chatterjee S., Whitley R. J., Roizman B. Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A. 1987 Jun;84(12):4303–4307. doi: 10.1073/pnas.84.12.4303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Marsden H. S., Buckmaster A., Palfreyman J. W., Hope R. G., Minson A. C. Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol. 1984 May;50(2):547–554. doi: 10.1128/jvi.50.2.547-554.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Muñoz A., Carrasco L. Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. J Gen Virol. 1984 Jun;65(Pt 6):1069–1078. doi: 10.1099/0022-1317-65-6-1069. [DOI] [PubMed] [Google Scholar]
  21. Oberman F., Panet A. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. J Gen Virol. 1988 Jun;69(Pt 6):1167–1177. doi: 10.1099/0022-1317-69-6-1167. [DOI] [PubMed] [Google Scholar]
  22. Pfeffer L. M., Landsberger F. R., Tamm I. Beta-interferon-induced time-dependent changes in the plasma membrane lipid bilayer of cultured cells. J Interferon Res. 1981;1(4):613–620. doi: 10.1089/jir.1981.1.613. [DOI] [PubMed] [Google Scholar]
  23. Roizman B., Norrild B., Chan C., Pereira L. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology. 1984 Feb;133(1):242–247. doi: 10.1016/0042-6822(84)90447-1. [DOI] [PubMed] [Google Scholar]
  24. Sahni G., Samuel C. E. Mechanism of interferon action. Expression of vesicular stomatitis virus G gene in transfected COS cells is inhibited by interferon at the level of protein synthesis. J Biol Chem. 1986 Dec 15;261(35):16764–16768. [PubMed] [Google Scholar]
  25. Straus S. E., Takiff H. E., Seidlin M., Bachrach S., Lininger L., DiGiovanna J. J., Western K. A., Smith H. A., Lehrman S. N., Creagh-Kirk T. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med. 1984 Jun 14;310(24):1545–1550. doi: 10.1056/NEJM198406143102401. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES